Ada Reid
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- SARS-CoV-2 and COVID-19 Research 1
- Journals
- The Lancet (3 papers)
In The Last Decade
Ada Reid
3 papers receiving 852 citations
Ada Reid's Hit Papers
Peers
Comparison fields: 5 of 84
- Infectious Diseases 558
- Applied Microbiology and Biotechnology 45
- Internal Medicine 56
- Neurology 185
- Obstetrics and Gynecology 40
Countries citing papers authored by Ada Reid
This map shows the geographic impact of Ada Reid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ada Reid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ada Reid more than expected).
Fields of papers citing papers by Ada Reid
This network shows the impact of papers produced by Ada Reid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ada Reid. The network helps show where Ada Reid may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 2 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 3 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
About Ada Reid
Ada Reid is a scholar working on Infectious Diseases, Insect Science, Renewable Energy, Sustainability and the Environment, Obstetrics and Gynecology and Anesthesiology and Pain Medicine, having authored 3 papers that have together received 896 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Infectious Diseases (558 citations), Applied Microbiology and Biotechnology (45 citations), Internal Medicine (56 citations), Neurology (185 citations) and Obstetrics and Gynecology (40 citations). Ada Reid has collaborated with scholars based in Indonesia, Nepal and Australia. Their work appears in journals such as The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.